(M+-CH3) and 325 (M+-TMS). From these fragmentation patterns, the location of the additional hydroxy group was not clear . The mass spectral properties, Rf values in TLC (Fig. 2) and GC data (Table 1) of this metabolite were, however, in good agreement with those of authentic 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one.
Metabolite ill
The mass spectrum of II as its TMS derivative gave the M+ at m/z 368, suggesting the hydroxylation of the parent compound (Table  2) Table   1 ) with those of the authentic compound.
Metabolite y
The mass spectrum of the TMS derivative of V showed the M+ at m/z 382, together with four diagnostic fragment peaks at m/z 367
(M+-COOTMS) and 237 (Table 2) . The peak at m/z 237 resulting from cleavage of the ether rinkage suggested that the metabolic conversion occurred on the isopropoxy sidechain. The W of this metabolite was 102 amu higher than that of the parent compound , suggesting the oxidation of the isopropyl moiety of TC-80 to the 1-carboxyethyl function. Formation of the carboxy group was also supported by the finding that V was methylated with diazomethane. Therefore, V was postulated to be 2-(3-phenyl-4-oxo-4H 1-benzopyran-7-yl)oxypropionic acid and identified by comparing its mass spectral properties and GC data (Table 1) with those of the authentic comnonnd. 3.1 .6 Metabolites VI and VII VI and VII were separated by GC (Table 1) and the mass spectra of the TMS derivatives of these metabolites gave the similar fragmentation patterns to each other ( Table 2) (Table 2 ).These two metabolites were, therefore, postulated to be position isomers with respect to the additional hydroxy group which was located on the isoflavone ring. By comparing the mass spectral data and GC retention times (Table 1) were thus identified. Of the metabolites characterized here, I and II were already isolated from dog urine and identified by MS (Uemura, unpublished).
Although we failed to identify lV in rats, this metabolite was isolated from the human urine and characterized as 2-(3-phenyl-4-oxo-4H-1-benz opyran-7-yl)oxypropyl alcohol by GC-MS (Uemura, unpublished). From these results, it is obvious that in rats TC-80 is metabolized primarily by oxidation: elimination of the isopropyl function, oxidation of the isopropyl group and hydroxylation of the B (phenyl) ring (Fig. 3 ). As will be described in our next paper4', all of the above metabolites are also detected in dogs. In addition, conjugation with glucuronic and/or sulfuric acid of I, II, III, IV, VI and VI occurs in both rats and dogs4). Such metabolic degradation does not occur with TC-80, since no significant amount of the compound was metabolized in the incubation with the cecal contents of rats, thus excluding the participation of gut flora in biotransformation of TC-80.
In conclusion, TC-80 is metabolized exclusively in the liver by elimination of the isopropyl group, oxidation of the isopropyl function and hydroxylation in the B ring followed by conjugation with glucuronic and/or sulfuric acid. 
